Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland

Nephrology Dialysis Transplantation

Volumn 31, Issue 3, 2016, Pages 439-447

  Okparavero, Aghogho ^a   Foster, Meredith C ^a   Tighiouart, Hocine ^a,b   Gudnason, Vilmundur ^c,d   Indridason, Olafur ^e   Gudmundsdottir, Hrefna ^d,e   Eiriksdottir, Gudny ^c   Gudmundsson, Elias F ^c   Inker, Lesley A ^a   Levey, Andrew S ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

albuminuria; chronic kidney disease; complications; elderly; prevalence

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C;

AGED; ALBUMIN TO CREATININE RATIO; ALBUMINURIA; ANEMIA; ANION GAP; ARTICLE; CHRONIC KIDNEY DISEASE; COMMUNITY SAMPLE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPOALBUMINEMIA; ICELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; METABOLIC ACIDOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGE; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; METABOLIC DISEASES; MULTICENTER STUDY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; VERY ELDERLY;

AGE FACTORS; AGED, 80 AND OVER; ANEMIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; ICELAND; MALE; METABOLIC DISEASES; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84960077863     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv370     Document Type: Article

References (30)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
2. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): S1-S266
4. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180
5. Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308: 2349-2360
6. Gansevoort RT, Matsushita K, van Der VeldeMet al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80: 93-104
7. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van Der VeldeM, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
8. Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
9. Inker LA, Coresh J, Levey AS, et al. Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol 2011; 22: 2322-2331
10. Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010; 55 (3 Suppl 2): S23-S33
11. Eustace JA, Astor B, Muntner PM, et al. Prevalence of acidosis and inflammation and their association with lowserum albumin in chronic kidney disease. Kidney Int 2004; 65: 1031-1040
12. Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009; 20: 164-171
13. Bowling CB, Inker LA, Gutierrez OM, et al. Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol 2011; 6: 2822-2828
14. Drawz PE, Babineau DC, Rahman M. Metabolic complications in elderly adults with chronic kidney disease. J Am Geriatr Soc 2012; 60: 310-315
15. Viswanathan G, Sarnak MJ, Tighiouart H, et al. The association of chronic kidney disease complications by albuminuria and glomerular filtration rate: a cross-sectional analysis. Clin Nephrol 2013; 80: 29-39
16. Muntner P, Jones TM, Hyre AD, et al. Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate. Clin J AmSoc Nephrol 2009; 4: 186-194
17. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J AmSoc Nephrol 2006; 17: 2275-2284
18. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117
19. Zhang QL, Koenig W, Raum E, et al. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009; 48: 122-127
20. Wang S, Chen R, LiuQ, et al. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: the China Health and Retirement Longitudinal Study. Nephrology (Carlton) 2015; 20: 474-484
21. Inker LA, Okparavero A, Tighiouart H, et al. Midlife blood pressure and late-life GFR and albuminuria: an elderly general population cohort. Am J Kidney Dis 2015; 66: 240-248
22. Harris TB, Launer LJ, Eiriksdottir G, et al. Age, gene/environment susceptibility-Reykjavik study: multidisciplinary applied phenomics. Am J Epidemiol 2007; 165: 1076-1087
23. Grubb A, Blirup-Jensen S, Lindstrom V, et al. First certified reference material for Cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010; 48: 1619-1621
24. Blirup-Jensen S, Grubb A, Lindstrom Vet al. Standardization of Cystatin C: development of primary and secondary reference preparations. Scand J Clin Lab Invest Suppl 2008; 241: 67-70
25. Selvin E, Juraschek SP, Eckfeldt J, et al. Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES). Am J Kidney Dis 2013; 61: 353-354
26. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29
27. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150
28. KDOQI Clinical Practice Guidelines and Clinical Practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47 (5 Suppl 3): S11-145
29. Lolekha PH, Vanavanan S, Lolekha S. Update on value of the anion gap in clinical diagnosis and laboratory evaluation. Clin Chim Acta 2001; 307: 33-36
30. Harrell FE, Jr. rms: Regression Modeling Strategies. R package version 3.6-0. http://CRAN.R-project.org/package=rms